Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Cooper-Standard Holdings, Inc. (CPS)
NYSEConsumer DiscretionaryAuto - PartsSnapshot 2026-11-04
$17.85-19.01%
Close 2026-11-05 · 1-day change
NYSEConsumer DiscretionaryAuto - PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.52 → 3.79 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CPS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain capital expenditures within $55-$65 million range in 2026 | The company plans to keep capital spending between $55 million and $65 million in 2026. | Broken | capital expenditures exceed $65 million or fall below $55 million in FY26 | Capital expenditures: $13.819M FY2026-Q2; GAAP. Published target: $55-$65 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 202613,819,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
CPS is a loss-making business with elevated risk, so this is an execution-dependent thesis rather than an established earnings compounder. The thesis is marked intact, but recent signals have turned cautious and company momentum has weakened.
The valuation evidence points to CPS being cheap versus peers, with a negative expectations gap, though confidence in that assessment is low. The priced-in signal is tagged as justified, and no fragility gates fired; this does not remove the risk tied to ongoing losses and earnings misses.
Near term, repeated earnings misses and an elevated risk of another miss make results and guidance important swing factors. Management remains on track with its stated 2026 sales and profitability priorities: second-quarter sales and adjusted EBITDA were higher than in the first quarter, and full-year sales guidance is maintained. Capital spending guidance is also on track, while cash taxes remain a watch item.
The next call is a key test: a guidance cut would be a meaningful negative, while continued delivery against 2026 targets would support the execution case. Over the near term, results and guidance from sector bellwethers GPC, BWA, and APTV could either sustain or weaken the sector tailwind affecting CPS.
Over the 1-to-3-year view, the thesis rests on CPS making progress toward its 2026 targets and improving its record of earnings execution. The business setup remains cautious, with loss-making status and near-term miss risk limiting confidence. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of 3 supplied quarters. Management reported: “Following actual reported results in the first half of the year, the Company believes it remains on track to achieve full-year results for sales and adjusted EBITDA in line with its original 2026 business plan.” “Following strong actual results in the first three months of the year, the Company believes it is on track to achieve or exceed the targeted ranges for sales and profitability as outlined in its formal guidance for 2026 issued in February.”
Improve earnings toward positive EPS in FY26 | A primary condition in Cooper-Standard Holdings, Inc.'s published investment case. The stated target is EPS >= $2.31. | Broken | EPS falls below $2.31 in FY26 | Diluted EPS: $-1.04 per share FY2026-Q2; GAAP. Published target: EPS >= $2.31. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 2026-1.04 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 3 supplied quarters. Management reported: “Following actual reported results in the first half of the year, the Company believes it remains on track to achieve full-year results for sales and adjusted EBITDA in line with its original 2026 business plan.” “Following strong actual results in the first three months of the year, the Company believes it is on track to achieve or exceed the targeted ranges for sales and profitability as outlined in its formal guidance for 2026 issued in February.” Delivery assessment Nov 4, 2026 |
Achieve or exceed 2026 revenue target near $2.7 billion | Cooper-Standard aims to meet or beat its 2026 sales target near $2.7 billion. | Intact | annual revenue falls below $2.7 billion in FY26 | Revenue: $721.349M FY2026-Q2; GAAP. Published target: >= $2.7 billion. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 2026721,349,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 3 supplied quarters. Management reported: “Following actual reported results in the first half of the year, the Company believes it remains on track to achieve full-year results for sales and adjusted EBITDA in line with its original 2026 business plan.” “Following strong actual results in the first three months of the year, the Company believes it is on track to achieve or exceed the targeted ranges for sales and profitability as outlined in its formal guidance for 2026 issued in February.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.42 → $3.79 · observed estimates
$2.98B → $2.97B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.42 | $2,978,766,670 | 3 / 3 |
| 2026-07-25 | $4.42 | $2,978,766,670 | 3 / 3 |
| 2026-07-26 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-07-27 | $4.42 | $2,978,766,670 | 3 / 3 |
| 2026-07-28 | $4.42 | $2,978,766,670 | 3 / 3 |
| 2026-07-29 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-07-30 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-07-31 | $4.42 | $2,978,766,670 | 3 / 3 |
| 2026-08-01 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-02 | $4.42 | $2,978,766,670 | 3 / 3 |
| 2026-08-03 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-04 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-05 | $4.42 | $2,978,766,670 | 3 / 3 |
| 2026-08-06 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-07 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-08 | $4.42 | $2,992,133,330 | 3 / 3 |
| 2026-08-09 | $4.42 | $2,992,133,330 | 3 / 3 |
| 2026-08-10 | $4.42 | $2,992,133,330 | 3 / 3 |
| 2026-08-11 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-12 | $4.48 | $2,992,133,330 | 3 / 3 |
| 2026-08-13 | $4.48 | $2,992,133,330 | 3 / 3 |
| 2026-08-14 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-15 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-16 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-17 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-18 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-19 | $4.42 | $2,978,766,667 | 1 / 2 |
| 2026-08-20 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-21 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-22 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-23 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-24 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-25 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-26 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-27 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-28 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-29 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-30 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-08-31 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-01 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-02 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-03 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-04 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-05 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-06 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-07 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-08 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-09 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-10 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-11 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-12 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-13 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-14 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-15 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-16 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-17 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-18 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-19 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-20 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-21 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-22 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-23 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-24 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-25 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-26 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-27 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-28 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-29 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-09-30 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-01 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-02 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-03 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-04 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-05 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-06 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-07 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-08 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-09 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-10 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-11 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-12 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-13 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-14 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-15 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-16 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-17 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-18 | $4.52 | $2,988,466,667 | 1 / 2 |
| 2026-10-19 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-20 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-21 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-22 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-23 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-24 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-25 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-26 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-27 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-28 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-29 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-30 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-10-31 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-11-01 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-11-02 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-11-03 | $3.79 | $2,967,066,667 | 1 / 2 |
| 2026-11-04 | $3.79 | $2,967,066,667 | 1 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.